Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Matthew J. Bentham"'
Autor:
Emma Brown, Gemma Swinscoe, Daniella A Lefteri, Ravi Singh, Amy Moran, Rebecca F Thompson, Daniel Maskell, Hannah Beaumont, Matthew J Bentham, Claire Donald, Alain Kohl, Andrew Macdonald, Neil Ranson, Richard Foster, Clive S McKimmie, Antreas C Kalli, Stephen Griffin
Publikováno v:
eLife, Vol 13 (2024)
Flaviviruses, including Zika virus (ZIKV), are a significant global health concern, yet no licensed antivirals exist to treat disease. The small membrane (M) protein plays well-defined roles during viral egress and remains within virion membranes fol
Externí odkaz:
https://doaj.org/article/2ea2a660429141029618f43cf5ee6d6c
Autor:
Joseph Shaw, Rajendra Gosain, Monoj Mon Kalita, Toshana L Foster, Jayakanth Kankanala, D Ram Mahato, Sonia Abas, Barnabas J King, Claire Scott, Emma Brown, Matthew J Bentham, Laura Wetherill, Abigail Bloy, Adel Samson, Mark Harris, Jamel Mankouri, David J Rowlands, Andrew Macdonald, Alexander W Tarr, Wolfgang B Fischer, Richard Foster, Stephen Griffin
Publikováno v:
eLife, Vol 9 (2020)
Since the 1960s, a single class of agent has been licensed targeting virus-encoded ion channels, or ‘viroporins’, contrasting the success of channel blocking drugs in other areas of medicine. Although resistance arose to these prototypic adamanta
Externí odkaz:
https://doaj.org/article/3401ae4371944442844f8b367aa9f459
Autor:
Joseph Shaw, Rajendra Gosein, Monoj Mon Kalita, Toshana L. Foster, Jayakanth Kankanala, D. Ram Mahato, Claire Scott, Barnabas J. King, Emma Brown, Matthew J. Bentham, Laura Wetherill, Abigail Bloy, Adel Samson, Mark Harris, Jamel Mankouri, David Rowlands, Andrew Macdonald, Alexander W. Tarr, Wolfgang B. Fischer, Richard Foster, Stephen Griffin
Since the 1960s, a single class of agent has been licensed targeting virus-encoded ion channels, or “viroporins”, contrasting the success of channel blocking drugs in other areas of medicine. Although resistance arose to these prototypic adamanta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b117e27714d45812e85ecaf3d8fdea0e
https://doi.org/10.1101/374793
https://doi.org/10.1101/374793
Autor:
Adel, Samson, Matthew J, Bentham, Karen, Scott, Gerard, Nuovo, Abigail, Bloy, Elizabeth, Appleton, Robert A, Adair, Rajiv, Dave, Adam, Peckham-Cooper, Giles, Toogood, Seishi, Nagamori, Matthew, Coffey, Richard, Vile, Kevin, Harrington, Peter, Selby, Fiona, Errington-Mais, Alan, Melcher, Stephen, Griffin
Publikováno v:
Gut
Objective Oncolytic viruses (OVs) represent promising, proinflammatory cancer treatments. Here, we explored whether OV-induced innate immune responses could simultaneously inhibit HCV while suppressing hepatocellular carcinoma (HCC). Furthermore, we